Condition
Inflammatory Myopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Inflammatory Myopathy clinical trials that are recruiting, at sites in 2 countries (most in China (10), United States (1)). By phase: Phase 1 (8), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 2Countries
Newest Inflammatory Myopathy clinical trials
All recruiting trials (11)
-
BCMA-CD19 cCAR-T cell therapy for refractory inflammatory myopathy
This trial tests a special CAR-T cell therapy (ICG318) in adults with refractory inflammatory myopathy to see if it is safe and tolerable.
-
TI-0032-III injection for relapsed and refractory B cell–related autoimmune diseases
This trial tests whether TI-0032-III, an injected therapy that delivers circular RNA instructions for a CD19 CAR to T cells, can help adults with relapsed or treatment‑resistant B cell–related autoimmune diseases such as SLE, Sjögren's, systemic sclerosis, inflammatory myopathy, or ANCA-associated vasculitis.
-
Patient-rooted insights to shape myositis science
This global project asks people living with myositis (and their care partners) to share experiences and rank research questions so the community can see which issues matter most.
-
YTS109 cell therapy for relapsed or treatment‑resistant autoimmune diseases
This will try a single infusion of YTS109 immune cells in adults 18–65 with relapsed or treatment‑resistant autoimmune diseases such as lupus, Sjogren’s, systemic sclerosis, inflammatory myopathies, or ANCA‑associated vasculitis.
-
YTS109 cell therapy for relapsed or refractory autoimmune diseases
This will try a single infusion of YTS109 immune cells to see if they are safe and help adults 18–65 with relapsed or refractory lupus (including lupus nephritis), Sjogren's syndrome, inflammatory myopathy, or ANCA‑associated vasculitis.
-
YTS109 cell therapy for relapsed/refractory autoimmune diseases
This trial will try a single infusion of YTS109 immune cells to see if they are safe and help adults aged 18–65 with relapsed or refractory autoimmune diseases such as lupus, Sjogren’s syndrome, inflammatory myopathy, or ANCA-associated vasculitis.
-
YTS109 cell therapy for relapsed or refractory autoimmune diseases
This trial will try a single infusion of YTS109 cells to see if they are safe and help adults (18–65) with relapsing or refractory autoimmune diseases such as SLE, lupus nephritis, systemic sclerosis, inflammatory myopathy, or ANCA-associated vasculitis.
-
YTS109 cell therapy for relapsed or refractory systemic autoimmune diseases
This trial will try a single infusion of YTS109 cells to see if it's safe and helps adults 18–65 with relapsed or refractory systemic autoimmune diseases such as SLE, systemic sclerosis, inflammatory myopathies, ANCA-associated vasculitis, or antiphospholipid syndrome.
-
CAR T-cell therapy for autoimmune diseases
This study is testing a new CAR T-cell therapy to see if it can help people with tough autoimmune diseases like lupus and systemic sclerosis feel better.
-
BCMA-CD19 CAR-T therapy for autoimmune diseases
This study is testing a new CAR-T cell therapy to see if it can help adults with tough autoimmune diseases feel better and improve their health.
-
YTS109 cell injection for autoimmune diseases
This study is testing if YTS109 cell injections can help people with stubborn autoimmune diseases feel better and improve their health.
Related topics
Quick answers
How many Inflammatory Myopathy clinical trials are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (10 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 8, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.